| IMV patient (n = 505) | Non-IMV patient (n = 889) | All patient (N = 1,394) | P value |
---|---|---|---|---|
Maternal characteristics | ||||
 Maternal hypertension, n (%) | 10 (2.0) | 17 (1.9) | 27 (1.9) | 0.9299 |
 GDM, n (%) | 21 (4.2) | 37 (4.2) | 58 (4.2) | 0.9974 |
 Antenatal steroid, n (%) | 0(0.0) | 2(0.2) | 2(0.1) | 0.1574 |
Delivery mode | ||||
 Vaginal delivery, n (%) | 341 (67.5) | 593 (66.7) | 934 (67.0) | 0.7540 |
 Cesarean section, n (%) | 164 (32.48) | 296 (33.3) | 460 (33.0) | 0.7540 |
Patient characteristics | ||||
 Gestational age (week) | 35.16 ± 4.17 | 37.44 ± 2.18 | 36.61 ± 3.25 |  < 0.001 |
 Birth weight (g) | 2,446.33 ± 903.33 | 2,897.44 ± 655.50 | 2,734.01 ± 784.98 |  < 0.001 |
 Birth height (cm) | 45.49 ± 5.11 | 47.72 ± 3.60 | 46.93 ± 4.33 |  < 0.001 |
 IUGR, n (%) | 58 (11.5) | 113 (12.7) | 171 (12.3) | 0.4978 |
   < 3 percentile, n (%) | 28 (5.5) | 50 (5.6) | 78 (5.6) | 0.9503 |
 Male, n (%) | 314 (62.2) | 518 (58.3) | 832 (59.7) | 0.1510 |
 CRIB II score | 1.79 ± 2.18 | 1.43 ± 1.50 | 1.43 ± 1.50 |  < 0.001 |
 Surfactant administration, n (%) | 0 (0.0) | 89 (10.0) | 89 (6.4) |  < 0.001 |
Underlying comorbidities, n (%) | ||||
 RDS | 260 (51.5) | 4(0.5) | 264 (18.9) |  < 0.001 |
 PDA | 90 (17.9) | 20 (2.2) | 110 (7.9) |  < 0.001 |
 BPD | 21 (4.2) | 2 (0.2) | 23 (1.7) |  < 0.001 |
 ROP | 7 (1.4) | 2 (0.2) | 9 (0.7) | 0.0334 |
 NEC | 16 (3.2) | 3 (0.3) | 19 (1.4) |  < 0.001 |
 Duration of hospitalization, mean ± SD (day) | 32.06 ± 31.93 | 8.98 ± 7.91 | 17.34 ± 23.06 |  < 0.001 |
 Mortality, n (%) | 38 (7.5) | 5 (0.6) | 43 (3.1) | 0.0000 |